Literature DB >> 15881197

Stability of frozen serum levels of insulin-like growth factor-I, insulin-like growth factor-II, insulin-like growth factor binding protein-3, transforming growth factor beta, soluble Fas, and superoxide dismutase activity for the JACC study.

Yoshinori Ito1, Kei Nakachi, Kazue Imai, Shuji Hashimoto, Yoshiyuki Watanabe, Yutaka Inaba, Akiko Tamakoshi, Takesumi Yoshimura.   

Abstract

BACKGROUND: Subjects of the Japan Collaborate Cohort Study (JACC Study) gave peripheral blood samples collected between 1988 and 1990. We conducted to investigate whether levels of serum components measured after 9 years of frozen storage are stable or not.
METHODS: To assess the degradation of frozen serum components in the JACC Study, we compared levels of various components (IGF-I, IGF-II, IGFBP-3, TGF-beta 1, sFas, and total SOD activity) between fresh and stored sera collected from other inhabitants. Serum levels of constituents were measured by immunoradiometric assay (IGF-I, IGF-II and IGFBP-3), quantitative enzyme immunoassay (TGF-beta1), enzyme-linked immuno-adsorbent assay (sFas), and an improved nitrite method (SOD activity).
RESULTS: The coefficients of variation for intra- and inter-assay precisions of the measurements were less than 9%. Levels of IGF-I, IGF-II, IGFBP-3, TGF-beta 1 and sFas in sera after storage for 9 years at--80 degrees C were similar to those of fresh sera newly collected from inhabitants. The distributions of serum IGF-I, IGF-II, IGFBP-3, TGF-beta 1, sFas and SOD activity for specimens collected from different individuals tended to be similar to those of serum levels for frozen specimens collected from different individuals and stored for 9 years.
CONCLUSIONS: There was no statistically significant difference in distribution of measured values of IGF-I, IGF-II, IGFBP-3, TGF-beta 1, and sFas between newly collected sera and frozen specimens stored for 9 years. Thus, measurements of these serum constituents of specimens stored for the JACC Study can be reliably used in nested case-control study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15881197     DOI: 10.2188/jea.15.s67

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  28 in total

Review 1.  Mass spectrometry based biomarker discovery, verification, and validation--quality assurance and control of protein biomarker assays.

Authors:  Carol E Parker; Christoph H Borchers
Journal:  Mol Oncol       Date:  2014-03-20       Impact factor: 6.603

2.  Serum insulin-like growth factor binding protein-1 levels and bone mineral density in older adults: the Rancho Bernardo Study.

Authors:  Simerjot K Jassal; Denise von Muhlen; Elizabeth Barrett-Connor; Clifford J Rosen
Journal:  Osteoporos Int       Date:  2005-08-09       Impact factor: 4.507

3.  Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness.

Authors:  Amy M Ahasic; Paula Tejera; Yongyue Wei; Li Su; Christos S Mantzoros; Ednan K Bajwa; B Taylor Thompson; David C Christiani
Journal:  Crit Care Med       Date:  2015-12       Impact factor: 7.598

4.  Evidence for threshold effects of 25-hydroxyvitamin D on glucose tolerance and insulin resistance in black and white obese postmenopausal women.

Authors:  John D Sorkin; Tadas Sean Vasaitis; Elizabeth Streeten; Alice S Ryan; Andrew P Goldberg
Journal:  J Nutr       Date:  2014-04-09       Impact factor: 4.798

5.  Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study.

Authors:  Yasushi Adachi; Masanori Nojima; Mitsuru Mori; Yasutaka Matsunaga; Noriyuki Akutsu; Shigeru Sasaki; Takao Endo; Youichi Kurozawa; Kenji Wakai; Akiko Tamakoshi
Journal:  Tumour Biol       Date:  2016-09-23

Review 6.  Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis.

Authors:  Mari-Anne Rowlands; David Gunnell; Ross Harris; Lars J Vatten; Jeff M P Holly; Richard M Martin
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

7.  Dietary predictors of the insulin-like growth factor system in adolescent females: results from the Dietary Intervention Study in Children (DISC).

Authors:  Jean M Kerver; Joseph C Gardiner; Joanne F Dorgan; Cliff J Rosen; Ellen M Velie
Journal:  Am J Clin Nutr       Date:  2010-01-20       Impact factor: 7.045

8.  Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort.

Authors:  Robert C Kaplan; Garrett Strizich; Chino Aneke-Nash; Clara Dominguez-Islas; Petra Bužková; Howard Strickler; Thomas Rohan; Michael Pollak; Lewis Kuller; Jorge R Kizer; Anne Cappola; Christopher I Li; Bruce M Psaty; Anne Newman
Journal:  J Clin Endocrinol Metab       Date:  2017-01-01       Impact factor: 5.958

9.  Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the Finnish Maternity Cohort.

Authors:  Katsiaryna Holl; Eva Lundin; Marjo Kaasila; Kjell Grankvist; Yelena Afanasyeva; Göran Hallmans; Matti Lehtinen; Eero Pukkala; Helja-Marja Surcel; Paolo Toniolo; Anne Zeleniuch-Jacquotte; Pentti Koskela; Annekatrin Lukanova
Journal:  Acta Oncol       Date:  2007-09-24       Impact factor: 4.089

Review 10.  The current status of IGF-I assays--a 2009 update.

Authors:  Jan Frystyk; Pamela Freda; David R Clemmons
Journal:  Growth Horm IGF Res       Date:  2009-10-08       Impact factor: 2.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.